In addition, Ozgen et al. found that the Galpha(q)- PKC-δ-PKD-CREB-Ser (126) phosphorylation pathway was involved in cardiac remodeling and could be used as a target for heart failure treatment (132). This evidence concerns the gene PRKCD and heart failure.